Xeris Biopharma Holdings Inc (XERS)

Free Cash Flow

$8.05M

Quarterly · Period ending: · USD

XERS logo

XERS Free Cash Flow

Latest reported$8.05M
XERS Quarterly Free Cash Flow (-$3.86M → $8.05M)
High-resolution chart · PNG

XERS free cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Free Cash Flow — Quarterly (USD)
Period endingFree Cash Flow (USD)
8,054,000
9,545,000
19,710,000
18,069,000
-97,000
-10,044,000
1,755,000
-8,392,000
-10,745,000
-20,467,000
6,154,000
-14,955,000
-15,292,000
-26,378,000
-16,251,000
-17,930,000
-20,825,000
-48,409,000
-29,077,000
-22,918,000
-20,240,000
-24,385,000
-11,094,000
-16,965,000
-23,905,000
-28,971,000
-29,816,000
-30,952,000
-23,331,000
-21,354,000
-18,585,000
-16,688,000
-14,378,000
-8,138,000
-9,336,000
-5,602,000
-6,564,000
-3,861,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.